BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22614186)

  • 21. The additive clinical value of 18F-FDG PET/CT in defining the recurrence of disease in patients with differentiated thyroid cancer who have isolated increased antithyroglobulin antibody levels.
    Ozkan E; Soydal C; Araz M; Aras G; Ibis E
    Clin Nucl Med; 2012 Aug; 37(8):755-8. PubMed ID: 22785502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 18F-FDG SPECT/CT in the diagnosis of differentiated thyroid carcinoma with elevated thyroglobulin and negative iodine-131 scans.
    Ma C; Wang X; Shao M; Zhao L; Jiawei X; Wu Z; Wang H
    Q J Nucl Med Mol Imaging; 2015 Jun; 59(2):220-7. PubMed ID: 24844253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The value of multimodal imaging by single photon emission computed tomography associated to X ray computed tomography (SPECT-CT) in the management of differentiated thyroid carcinoma: about 156 cases].
    Mhiri A; El Bez I; Slim I; Meddeb I; Yeddes I; Ghezaiel M; Gritli S; Ben Slimène MF
    Tunis Med; 2013 Oct; 91(10):589-93. PubMed ID: 24281999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [SPECT/CT for staging and treatment monitoring in oncology. Applications in differentiated thyroid cancer and liver tumors].
    Weber K; Berger F; Mustafa M; Reiser MF; Bartenstein P; Haug A
    Radiologe; 2012 Jul; 52(7):646-52. PubMed ID: 22710988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical utility of 18F-FDG PET/CT concurrent with 131I therapy in intermediate-to-high-risk patients with differentiated thyroid cancer: dual-center experience with 286 patients.
    Lee JW; Lee SM; Lee DH; Kim YJ
    J Nucl Med; 2013 Aug; 54(8):1230-6. PubMed ID: 23813775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ¹²⁴I PET/CT in the pretherapeutic staging of differentiated thyroid carcinoma: comparison with posttherapy ¹³¹I SPECT/CT.
    de Pont C; Halders S; Bucerius J; Mottaghy F; Brans B
    Eur J Nucl Med Mol Imaging; 2013 May; 40(5):693-700. PubMed ID: 23340593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Diagnostic
    Spanu A; Nuvoli S; Gelo I; Mele L; Piras B; Madeddu G
    J Nucl Med; 2018 Oct; 59(10):1510-1515. PubMed ID: 29496990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hybrid SPECT/CT Imaging in the Management of Differentiated Thyroid Carcinoma.
    Ahmed N; Niyaz K; Borakati A; Marafi F; Birk R; Usmani S
    Asian Pac J Cancer Prev; 2018 Feb; 19(2):303-308. PubMed ID: 29479949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incremental value of 99mTc-MDP hybrid SPECT/CT over planar scintigraphy and SPECT in avascular necrosis of the femoral head.
    Agarwal KK; Mukherjee A; Sharma P; Bal C; Kumar R
    Nucl Med Commun; 2015 Oct; 36(10):1055-62. PubMed ID: 26308940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can (18)F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?
    Bannas P; Derlin T; Groth M; Apostolova I; Adam G; Mester J; Klutmann S
    Ann Nucl Med; 2012 Jan; 26(1):77-85. PubMed ID: 22006540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hybrid SPECT-CT and PET-CT imaging of differentiated thyroid carcinoma.
    Wong KK; Zarzhevsky N; Cahill JM; Frey KA; Avram AM
    Br J Radiol; 2009 Oct; 82(982):860-76. PubMed ID: 19433487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of ¹³¹I SPECT/CT for the evaluation of differentiated thyroid cancer: a systematic review of the literature.
    Xue YL; Qiu ZL; Song HJ; Luo QY
    Eur J Nucl Med Mol Imaging; 2013 May; 40(5):768-78. PubMed ID: 23242250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of FDG-PET/CT in differentiated thyroid cancer patients with negative iodine-131 whole-body scan and elevated anti-Tg level.
    Asa S; Aksoy SY; Vatankulu B; Aliyev A; Uslu L; Ozhan M; Sager S; Halac M; Sonmezoglu K
    Ann Nucl Med; 2014 Dec; 28(10):970-9. PubMed ID: 25120245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of subcentimeter metastatic cervical lymph node by 18F-FDG PET/CT in patients with well-differentiated thyroid carcinoma and high serum thyroglobulin but negative 131I whole-body scan.
    Kunawudhi A; Pak-art R; Keelawat S; Tepmongkol S
    Clin Nucl Med; 2012 Jun; 37(6):561-7. PubMed ID: 22614187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic value of ⁹⁹mTc-MDP SPECT/spiral CT in assessing indeterminate spinal solitary lesion of patients without malignant history.
    Jiang L; Han L; Tan H; Hu P; Zhang Y; Shi H
    Ann Nucl Med; 2013 Jun; 27(5):460-7. PubMed ID: 23459868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The value of simultaneous co-registration of 99mTc- MDP and 131Iodine in metastatic differentiated thyroid carcinoma.
    Kotb MH; Omar W; El-Maghraby T; El-Bedwihy M; El-Tawdy M; Mustafa H; Al-Nahhas A
    Nucl Med Rev Cent East Eur; 2007; 10(2):98-105. PubMed ID: 18228214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors.
    Spanu A; Solinas ME; Farris A; Arru A; Chessa F; Madeddu G; Falchi A; Madeddu G
    Radiol Med; 2004; 107(1-2):113-27. PubMed ID: 15031703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SPECT/CT in patients with lower back pain after lumbar fusion surgery.
    Sumer J; Schmidt D; Ritt P; Lell M; Forst R; Kuwert T; Richter R
    Nucl Med Commun; 2013 Oct; 34(10):964-70. PubMed ID: 23820764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of [(18)F]-fluorodeoxy-D-glucose positron emission tomography and computed tomography in the early detection of persistent/recurrent thyroid carcinoma in intermediate-to-high risk patients following initial radioactive iodine ablation therapy.
    Kim MH; O JH; Ko SH; Bae JS; Lim DJ; Kim SH; Baek KH; Lee JM; Kang MI; Cha BY; Lee KW
    Thyroid; 2012 Feb; 22(2):157-64. PubMed ID: 22224820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 99mTc-Methylene diphosphonate SPECT/CT as the one-stop imaging modality for the diagnosis of osteoid osteoma.
    Sharma P; Mukherjee A; Karunanithi S; Nadarajah J; Gamanagatti S; Khan SA; Bal C; Kumar R
    Nucl Med Commun; 2014 Aug; 35(8):876-83. PubMed ID: 24751704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.